Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

GAITHERSBURG, Md., Aug. 23 /PRNewswire/ -- MedImmune, Inc. today announced that in a Phase 3 study, motavizumab was shown to reduce hospitalizations due to respiratory syncytial virus (RSV) by 83 percent as compared to placebo (8.3 percent in placebo arm vs. 1.4 percent in motavizumab; p<0.001), as the trial's primary endpoint. In addition, the trial showed a 71-percent reduction in the incidence of RSV-specific lower respiratory infections (LRIs) requiring outpatient management (9.5 percent in placebo group and 2.8 percent in the motavizumab group; p<0.001), which was a secondary endpoint.

Motavizumab is an investigational monoclonal antibody (MAb) being evaluated for its potential to prevent serious disease caused by RSV in high-risk pediatric patients. This Phase 3 trial involved 1,410 full-term infants less than six months of age in two Native American populations. In previous medical studies these populations were shown to have high rates of hospitalization due to RSV.

The randomized (2:1), double-blind study was designed to compare monthly intramuscular injections of motavizumab against placebo. After an interim analysis conducted by an independent data safety monitoring committee, the study was unblinded early due to statistical evidence demonstrating that motavizumab reduced RSV hospitalizations and LRIs requiring outpatient medical management within this population. Kate O'Brien, M.D., associate professor at the Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, served as the study's principal investigator.

"We are pleased with the results of this study which support the positive results seen in our Phase 3 pivotal trial comparing motavizumab and Synagis(R) (palivizumab) that were previously reported at the Pediatric Academic Societies meeting in May 2007," said Genevieve Losonsky, M.D., vice president, clinical development, infectious disease, MedImmune.

Motavizumab was well tolerated in these
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... N.J. , May 21, 2013  Armada ... launch of the new Armada corporate website ( ... clearly communicate Armada,s unique and first-to-market services and ... company focused on the specialty pharmacy industry. ... expansion of the Armada business model in delivering ...
(Date:5/21/2013)... Hurel Corporation ("Hurel"), a world-leading provider of ... today announced the appointment of James S. ... of Directors. Dr. MacDonald is the former Executive Vice ... ("SPRI"), which was the pharmaceutical development arm of Schering ... in 2009. Over a career that has ...
(Date:5/21/2013)... Pa. , May 21, 2013  Lehigh Valley ... TRU-D SmartUVC TM devices, adding to its existing ... seven devices taking up residence within the network, LVHN ... the U.S. to proactively combat superbugs and provide the ... for Total Room Ultraviolet Disinfector, TRU-D – the signature ...
Breaking Medicine Technology:Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3
... - CytoGenix, Inc. (CYGX.OB),announced today that Dr. Yin ... preclinical animal data for DNA vaccines made,using the ... conference to be held in Malaga, Spain between ... have successfully conducted tests of,synDNA(TM) based vaccines in ...
... WIRE)--May 23, 2007 -,ProtoKinetix Inc. (OTCBB:PKTX) has just ... Inc. at the University of Finland.,These outstanding results ... demonstrate the vital importance of this,molecule in the ... series of tests using AAGP(TM) on human embryonic ...
Cached Medicine Technology:CytoGenix to Present at 2007 International DNA Vaccines Conference,in Spain 2ProtoKinetix's AAGP Dramatically Increases Recovery Rate of,Cryopreserved Stem Cells 2
(Date:5/21/2013)... Charlotte, NC (PRWEB) May 21, 2013 ... Greater Charlotte will hold a free Community Wellness Fair ... screenings. The fair will be held on Wednesday, May ... University City YMCA (8100 Old Mallard Creek Road, ... American Heart Association and the Mecklenburg County ...
(Date:5/21/2013)... Paris, France: The Orsiro stent, which is a ... polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting ... late lumen loss at nine months in the ... 2013 today. , The BIOFLOW-II substudy used intravascular ... quantitatively assess neointimal hyperplasia and stent apposition at ...
(Date:5/21/2013)... Fla. (PRWEB) May 21, 2013 The ... distributed on cable networks and cable channels across the ... episodes on its YouTube channel. The producers of the ... companies in the shipping industry, the manufacturing industry, health-related ... pioneering medical facilities and medical practitioners in all parts ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 MedMar Healing ... drive to benefit Second Harvest Food Bank. Twenty-eight businesses, including ... participate in the food drive. The goal is to raise ... the economic problems facing their families in recent years. ... community and help those in need,” explains Douglas Chloupek of ...
(Date:5/21/2013)... (May 21, 2013) Research into genetic features of ... of Colorado School of Medicine may lead to improved ... paper published online by JAMA . , The ... survival in some cases of pulmonary fibrosis, a chronic ... As a result of the study, researchers may want ...
Breaking Medicine News(10 mins):Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2
... culprits behind the increase, , , THURSDAY, Aug. 30 (HealthDay ... sport early -- playing year-round, joining competitive club or ... believing they,ll put themselves on the fast track to ... , But for too many of these kids, that ...
... two Presidential Assassins off display, to attend the ... PHILADELPHIA, Aug. 30 The Mutter Museum in,collaboration ... of two,of the nation,s presidential assassins from its collection ... Wednesday, September 19. A,portion of the brain of Charles ...
... CUPERTINO, Calif., Aug. 30 Dr. Barry Karlin,Chairman ... leader in specialized,behavioral health care has announced the ... Pedro Road, San Rafael, CA 94901). Located ... in the,hills overlooking San Francisco Bay. The facility ...
... 2007, RICHMOND, Va., Aug. 30 While nearly ... tissue donation in,2006, strongly held myths regarding donation continue ... organ and tissue donors. In,recognition of Hispanic Heritage Month, ... Hispanic community, long celebrated for its,zest for life, to ...
... Cogdell Spencer Inc.,(NYSE: CSA ) announced this ... and II in Brunswick, Georgia for approximately $24.8,million ... square feet and is,98 percent leased. This ... client relationship,for Cogdell Spencer. Southeast Georgia Health System, ...
... Aug. 30 Matrixx Initiatives, Inc.,(Nasdaq: MTXX ), ... provide consumers with "Better Ways to Get,Better(R)," will be ... 2007 New York Conference. The Company will be ... live,presentation please visit http://www.matrixxinc.com . Interested parties,should login ...
Cached Medicine News:Health News:More Kids Are Suffering Sports Injuries 2Health News:More Kids Are Suffering Sports Injuries 3Health News:The Mutter Assassins Go to the Theater! 2Health News:The Mutter Assassins Go to the Theater! 3Health News:CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael 2Health News:Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month 2Health News:Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia 2Health News:Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference 2
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
... offers a display, ramp capabilities ... also has features that make ... session meter records the number ... than four hours - giving ...
... CPAP System is the smallest and lightest ... the market. It is designed to help ... while complying with therapy. The GoodKnight 420S ... date/time usage data. It also detects persistent ...
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
Medicine Products: